Breakthrough Requests: FDA Adds Quick Screen To Pare Workload
This article was originally published in The Pink Sheet Daily
Executive Summary
Hope is to quickly reject obviously inadequate designation requests, but few meet criteria for dismissal so far.
You may also be interested in...
Sponsors, FDA Reviewers To Get More Flexibility Under New User Fee Program
Next iteration of PDUFA will feature new communication plans that allow FDA and sponsors to drop mid-review meetings if desired.
FDA's Breakthrough Bar May Be Set Too Low, Jenkins Says
Office of New Drugs Director recommends that EMA be careful how its sets the bar for its similar PRIME program to ensure it remains meaningful.
Breakthrough Designation Can Be 'Lever' For Manufacturing Evolution, FDA Says
CDER Director Woodcock notes breakthrough program often pushes sponsors to modernize production processes.